trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Controlling blood glucose levels reduces the risk of serious health complications from diabetes such as vision loss and heart problems.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that controlling blood glucose levels reduces the risk of serious health complications from diabetes such as vision loss and heart problems?

Yes. Controlling blood glucose levels is a cornerstone of diabetes management, heavily supported by clinical literature for reducing long-term microvascular and macrovascular complications.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently confirms that maintaining glycemic control reduces the risk of long-term microvascular and cardiovascular complications associated with diabetes. While rapid correction can occasionally trigger acute side effects like treatment-induced neuropathy, the overarching consensus across clinical trials and reviews strongly supports the claim.

Evidence for · 5
The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications Trial
1996
Demonstrates that long-term glycemic exposure is the principal determinant of retinopathy and other microvascular complications, showing continuous risk reduction as HbA1c approaches normal levels.
Get citation
The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications Trial. (1996). doi.org. https://doi.org/10.2337/diab.45.10.1289

See more details
More for · 4
Vascular complications of type 2 diabetes mellitus beyond the reach of glycemic control
2010
Indicates that normalization of glycemia is aimed at reducing acute and late vascular complications of type 2 diabetes.
Get citation
Demidova, T. Y. (2010). Vascular complications of type 2 diabetes mellitus beyond the reach of glycemic control. doi.org. https://doi.org/10.14341/2072-0351-5498

Early insulin initiation in type 2 diabetes: efficacy, safety, and clinical implications: a systematic review with narrative synthesis.
2026
Shows that early glycemic improvement via insulin initiation helps preserve beta-cell function and potentially reduce long-term complications.
Get citation
O, A., AH, M., N, A., A, H., DAM, A., F, A., A, A., AY, M., LAM, E. H., T, M., M, M., AA, A., H, A., A, M., & A, H. (2026). Early insulin initiation in type 2 diabetes: efficacy, safety, and clinical implications: a systematic review with narrative synthesis.. doi.org. https://doi.org/10.3389/fendo.2026.1843227

Beyond Glycemic Control: Integrating Positive Psychology and Prospection into Nutritional Intervention for Type 2 Diabetes Management
2026
Notes that traditional clinical targets focusing on glycemic avoidance and HbA1c control are necessary for preventing vascular complications.
Get citation
RD, P. (2026). Beyond Glycemic Control: Integrating Positive Psychology and Prospection into Nutritional Intervention for Type 2 Diabetes Management. doi.org. https://doi.org/10.21203/rs.3.rs-11079031/v1

Plasma Homocysteine as a Biomarker for Cardiovascular Risk Stratification in Children and Adolescents With Type 1 Diabetes Mellitus: A Cross-Sectional Study From Western Algeria.
2026
Finds that poor glycemic control in diabetic patients is significantly associated with unfavorable cardiovascular risk profiles and elevated biomarkers of vascular injury.
Get citation
A, A., C, L., H, N., F, A., N, A., & K, B. N. (2026). Plasma Homocysteine as a Biomarker for Cardiovascular Risk Stratification in Children and Adolescents With Type 1 Diabetes Mellitus: A Cross-Sectional Study From Western Algeria.. doi.org. https://doi.org/10.7759/cureus.115169

What does the evidence say?

The retrieved literature consistently confirms that maintaining glycemic control reduces the risk of long-term microvascular and cardiovascular complications associated with diabetes. While rapid correction can occasionally trigger acute side effects like treatment-induced neuropathy, the overarching consensus across clinical trials and reviews strongly supports the claim.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work